Most authorities define patients as infertile if they have been unable to achieve a pregnancy after one year of unprotected intercourse. The fact is, among 60% of all couples experiencing infertility, a male factor is involved. In approximately 40 % of cases in the male alone and in another 20% both male and female are abnormal. Oligozoospermia refers to semen with a low concentration of sperm and is a common finding in male infertility. There is no possibility of such recurrence by Virechana Procedure. In addition, it is said that Virechana enhances the quality level of Shukra (Semen). For the clinical study, 40 male patients suffering from the primary or secondary infertility for more than one year and having sperm count less than 15 million/ml were selected irrespective of religion, caste and the status of seminal parameters was compared before and after Virechana procedure. Statistical analysis of the obtained data revealed that performing of Virechana provided increase 8.68 million/ml which was increased to 26.53 million /ml after completion of Virechana procedure with 72.50% increase in total which was statistically highly significant. Abnormal form of sperm decreased by 20.74% and the 24.08% increase in serum LH level was reported which was also statistically highly significant. This indicates that performing of Virechana alone can provide significant increase in total sperm count.
Hypertriglyceridemia is a commonly encountered lipid abnormality frequently associated with other lipid and metabolic disorder. It is defined as an abnormal concentration of triglyceride in the blood and has been associated with atherosclerosis even in the absence of hyper cholesterolemia and is identified as a potential risk factor for multitudes of diseases like Cardiac Vascular Disease (CVD), metabolic syndrome & even Hypertension. The state of Apakva Kapha and Margavarana in Rasa-Raktavaha Srotasa can be compared with the state of Hypertriglyceridemia. Hence a compound was formulated named Meshashringyadi Guggulu containing equal parts of Meshashringi, Lasuna, Katuki and Guggulu along with life style modification. An open labelled clinical study with pre-test & post-test design was carried on 20 patients of either sex of Hypertriglyceridemia. These patients were given Capsule Meshashrigyadi Guggulu two capsules of 500mg each thrice daily before breakfast, lunch and dinner with lukewarm water for the duration of eight weeks. These patients were also advised strict life style modifications. Analysis of data showed that combined effect of the trial drug and life style intervention provided statistically significant changes in S. Triglyceride levels in these patients of Hypertriglyceridemia. As Hypertriglyceridemia is a condition arising from faulty life style, its management needs equal attention for treatment and prevention which can be achieved by administering Medohara drugs having Agnideepana properties and following appropriate life style modification.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.